Shares of vaccine stocks are trading lower amid a possible selloff after the sector gained amid rising cases. It was recently reported doctors are observing a milder disease amid hospitalization. Additionally, Pfizer said it expects a 24% vaccination rate this year.
Portfolio Pulse from Benzinga Newsdesk
Vaccine stocks are experiencing a downturn following a surge due to increasing COVID-19 cases. This comes as doctors report a milder disease among hospitalized patients.
September 18, 2023 | 4:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BioNTech's stock is likely to be affected by the reported selloff in the vaccine sector.
As a major player in the vaccine sector, BioNTech's stock is likely to be impacted by the overall market sentiment. The reported selloff could lead to a decrease in the stock's price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Moderna's stock could be negatively impacted by the reported selloff in the vaccine sector.
Moderna, being a significant player in the vaccine sector, is likely to be affected by the overall market sentiment. The reported selloff could lead to a decrease in the stock's price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Novavax's stock is likely to be negatively impacted by the reported selloff in the vaccine sector.
Novavax, as a key player in the vaccine sector, is likely to be affected by the overall market sentiment. The reported selloff could lead to a decrease in the stock's price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Pfizer's stock could be negatively impacted by the reported selloff in the vaccine sector.
Pfizer, being a major player in the vaccine sector, is likely to be affected by the overall market sentiment. The reported selloff could lead to a decrease in the stock's price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100